Holen Sie sich die Stockscreener-App
21.54
1.27%
0.27
Handel nachbörslich:
21.12
-0.42
-1.95%
Vera Therapeutics Inc Aktie (VERA) Neueste Nachrichten
Vera Therapeutics shares fall 2.84% premarket after announcing inducement grants to new employees. - AInvest
Is Vera Therapeutics Inc. stock a hidden gemSmart Portfolio Allocation - thegnnews.com
Vera Therapeutics (NASDAQ:VERA) Price Target Cut to $53.00 by Analysts at JPMorgan Chase & Co. - MarketBeat
What makes Vera Therapeutics Inc. stock price move sharplyFree Portfolio Health Check - thegnnews.com
Custom watchlist performance reports with Vera Therapeutics Inc.Portfolio Safety Metrics and Return Analysis - Newser
HC Wainwright Analysts Lower Earnings Estimates for VERA - Defense World
Cantor Fitzgerald Issues Negative Forecast for VERA Earnings - Defense World
Vera Therapeutics, Inc. (NASDAQ:VERA) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
J.P. Morgan Maintains Vera Therapeutics(VERA.US) With Buy Rating, Cuts Target Price to $53 - 富途牛牛
Vera Therapeutics Inc. stock daily chart insightsTrade Ideas Based on Fundamental Metrics - Newser
Vera Therapeutics: Equity Incentives and BLA Timelines Signal Confidence in Value Creation - AInvest
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Vera Therapeutics Awards Major Stock Package: 99,000 Options, 48,200 RSUs to Expand Team - Stock Titan
Will Vera Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsFree Trend Analysis for Safer Trades - Newser
Wedbush Research Analysts Reduce Earnings Estimates for VERA - Defense World
Vera Therapeutics (VERA) to Release Quarterly Earnings on Thursday - Defense World
Can volume confirm reversal in Vera Therapeutics Inc.Free Capital Growth With Controlled Risk Picks - Newser
Vera Therapeutics Advances Clinical Trials and Financials Amid Progress Toward Commercial Launch - AInvest
Vera Therapeutics Q2 Net Loss Doubles, Revenue at $76.5 Million - AInvest
Vera (VERA) Q2 Net Loss Widens 127% - The Motley Fool
Vera Therapeutics Reports Progress in Clinical Trials - TipRanks
A Quick Look at Today's Ratings for Vera Therapeutics(VERA.US), With a Forecast Between $60 to $85 - 富途牛牛
Bkv Corporation shares rise 1.82% after-hours following Vera Therapeutics' positive trial results and upcoming BLA submission. - AInvest
Vera Therapeutics Signs New Sales Agreement with TD Securities - TipRanks
Vera Therapeutics files for offering of up to $200 million Class A Common Stockfiling - MarketScreener
Form 424B5 Vera Therapeutics, Inc. - StreetInsider
Vera Therapeutics sees cash funding operations through launch of atacicept - TipRanks
Vera Therapeutics reports Q2 EPS ($1.20), consensus (62c) - TipRanks
Vera Therapeutics announces anticipated upcoming milestones - TipRanks
Vera Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results - The Manila Times
Vera Therapeutics shares fall 2.20% premarket after Q2 net loss widens and Wolfe Research downgrade. - AInvest
Trendlines Converge — Decision Point for Vera Therapeutics Inc.Momentum Based Equity Trading Plans Reviewed - metal.it
Vera Therapeutics Shares Fall After Downgrade From Wolfe Research - MarketScreener
Wolfe Research downgrades Vera Therapeutics stock rating on limited catalysts - Investing.com Canada
This AvalonBay Communities Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Monday - Benzinga
Vera Therapeutics downgraded to Peer Perform from Outperform at Wolfe Research - TipRanks
Vera Therapeutics Inc.’s Price Action Aligns with Quant SignalsFast Exit and Entry Strategy Guide Offered - metal.it
How volatile is Vera Therapeutics Inc. stock compared to the marketAchieve breakthrough financial results today - Jammu Links News
Is Vera Therapeutics Inc. a growth stock or a value stockBuild wealth faster with expert stock selection - Jammu Links News
Is Vera Therapeutics Inc. a good long term investmentAchieve breakthrough profits with expert advice - Jammu Links News
How strong is Vera Therapeutics Inc. company’s balance sheetPowerful profit generation - Jammu Links News
What are the latest earnings results for Vera Therapeutics Inc.Breakthrough wealth creation - Jammu Links News
Vera Therapeutics Inc. Stock Analysis and ForecastAchieve breakthrough performance with smart picks - Jammu Links News
What is the dividend policy of Vera Therapeutics Inc. stockBuild your wealth with consistent stock growth - Jammu Links News
What catalysts could drive Vera Therapeutics Inc. stock higher in 2025Discover breakthrough stocks before the crowd - Jammu Links News
What are Vera Therapeutics Inc. company’s key revenue driversStay ahead with daily expert stock picks - Jammu Links News
Does Vera Therapeutics Inc. stock perform well during market downturnsUnlock exclusive trading strategies - Jammu Links News
What is Vera Therapeutics Inc. company’s growth strategyFree Real-Time Stock Data - Jammu Links News
What are the technical indicators suggesting about Vera Therapeutics Inc.Free Buy/Sell Signal Notifications - Jammu Links News
Short Interest Drops in Vera Therapeutics Inc. After RallyCommunity Strategy With High Win Rate Backtested - metal.it
Top Risks to Consider Before Buying Vera Therapeutics Inc. StockHigh Conviction Intraday Stock Signals Detected - metal.it
Vera Therapeutics shares fall 2.21% intraday as Alnylam Pharmaceuticals reports strong Q2 2025 results. - AInvest
Published on: 2025-07-30 16:01:27 - metal.it
Can Vera Therapeutics Inc. stock recover from recent declineWeekly Hot Picks With Buy Confidence Released - beatles.ru
0.44%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):